CAS 66750-10-5: N-Phenylaza-15-crown-5
Formula:C16H25NO4
InChI:InChI=1S/C16H25NO4/c1-2-4-16(5-3-1)17-6-8-18-10-12-20-14-15-21-13-11-19-9-7-17/h1-5H,6-15H2
InChI key:InChIKey=SGDQOAKAHLFKBV-UHFFFAOYSA-N
SMILES:O1CCOCCOCCN(C=2C=CC=CC2)CCOCC1
- Synonyms:
- N-Phenylaza-15-crown-5
- 1,4,7,10-Tetraoxa-13-azacyclopentadecane, 13-phenyl-
- 13-Phenyl-1,4,7,10-tetraoxa-13-azacyclopentadecane
- 1-N-Phenylaza-15-crown-5
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | N-PHENYLAZA-15-CROWN 5-ETHER REF: IN-DA003TB6CAS: 66750-10-5 | 99% | To inquire | Thu 27 Mar 25 |
![]() | N-Phenylaza-15-crown 5-ether REF: 54-OR72925CAS: 66750-10-5 | - - - | 73.00 €~845.00 € | Fri 28 Mar 25 |
![]() | N-Phenylaza-15-crown 5-Ether REF: 3B-P1143CAS: 66750-10-5 | >96.0%(GC)(T) | 88.00 €~308.00 € | Mon 21 Apr 25 |
![]() | N-Phenylaza-15-crown 5-Ether REF: 3D-FP62094CAS: 66750-10-5 | Min. 95% | - - - | Discontinued product |

N-PHENYLAZA-15-CROWN 5-ETHER
CAS:66750-10-5
Formula:
C16H25NO4
Purity:
99%
Color and Shape:
Solid
Molecular weight:
295.374
Ref: IN-DA003TB6
1g | 266.00 € | ||
5g | To inquire | ||
100mg | 101.00 € | ||
250mg | 140.00 € |
Estimated delivery in United States, on Thursday 27 Mar 2025

Ref: 54-OR72925
1g | 222.00 € | ||
5g | 845.00 € | ||
100mg | 73.00 € | ||
250mg | 87.00 € |
Estimated delivery in United States, on Friday 28 Mar 2025

N-Phenylaza-15-crown 5-Ether
CAS:66750-10-5
Formula:
C16H25NO4
Purity:
>96.0%(GC)(T)
Color and Shape:
White to Light yellow to Light red powder to crystal
Molecular weight:
295.38
Ref: 3B-P1143
1g | 88.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025

N-Phenylaza-15-crown 5-Ether
CAS:66750-10-5
N-Phenylaza-15-crown 5-ether (NPCE) is a thermodynamically stable and chemically unreactive compound. It can be used …
Purity:
Min. 95%
Ref: 3D-FP62094
1g | Discontinued | Request information | |
2g | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |